Incidence of Candidemia Is Higher in COVID-19 versus Non-COVID-19 Patients, but Not Driven by Intrahospital Transmission [PDF]
, 2022 There is scarce information on the actual incidence of candidemia in COVID-19 patients. In addition, comparative studies of candidemia episodes in COVID-19 and non-COVID-19 patients are heterogeneous.
Alonso Fernández, Roberto +9 more
core +2 more sources
Comparison of Fluconazole with Oral Probiotic and Fluconazole in the Treatment of Vulvovaginal Candidiasis : A Systematic Review And Meta-Analysis Of RCT Studies [PDF]
Vulvovaginal candidiasis, a common fungal infection that affects up to 75% of women at least once in their lifetime. With increasing resistance to azole antifungals, such as fluconazole, due to factors such as gene efflux pumps, alternative treatments ...
Prasasty, Gita Dwi +2 more
core +2 more sources
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap [PDF]
, 2023 Candida parapsilosis is one of the most commen causes of life-threatening candidaemia, particularly in premature neonates, individuals with cancer of the haematopoietic system, and recipients of organ transplants. Historically, drug-susceptible strains
Daneshnia, Farnaz +5 more
core +1 more source
Clinical Microbiology and Infection, 2021 OBJECTIVES Ibrexafungerp is a new oral glucan synthase inhibitor with in vivo and in vitro activity against Candida spp, including echinocandin- and azole-resistant isolates.
Aina Mesquida +5 more
semanticscholar +1 more source
Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi
Advanced Science, Volume 12, Issue 37, October 6, 2025.The growing burden of drug‐resistant fungal infections, driven by pathogens such as Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus, underscores the urgent need for novel antifungal therapies. This review explores antimicrobial peptides as promising agents with membrane‐disruptive activity, immunomodulatory properties, and delivery ...
Cesar Augusto Roque‐Borda +12 more
wiley +1 more source
Aspiring Antifungals: Review of Current Antifungal Pipeline Developments
Journal of Fungi, 2020 Invasive fungal infections are associated with significant morbidity and mortality, and their management is restricted to a variety of agents from five established classes of antifungal medication.
Thomas J. Gintjee +2 more
doaj +1 more source
Epidemiological Characterization of Clinical Fungal Isolates from Pauls Stradins Clinical University Hospital, Latvia: : A 4-year Surveillance Report [PDF]
, 2021 Funding Information: The authors are extremely grateful of the management of Pauls Stradin? Clinical University Hospital (PSCUH) and the supporting hospital and laboratory staff for their support in the present study.
Jain, Nityanand +6 more
core +1 more source
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 2, Page 377-388, February 2025.Nakaseomyces glabratus (formerly known as Candida glabrata) is an endogenous opportunistic pathogen that causes various clinical manifestations, ranging from mucocutaneous overgrowth to bloodstream infections. This review aims to summarize the biology, epidemiology and pathology of N.
Carmen Rodríguez‐Cerdeira +8 more
wiley +1 more source
Fungal lung disease encompasses a wide spectrum of organisms and associated clinical conditions, presenting a significant global health challenge. The type and severity of disease are determined by underlying host immunity and infecting fungal strain ...
Agarwal, Ritesh +9 more
core +1 more source
Guideline adherence and survival of patients with candidaemia in Europe:results from the ECMM Candida III multinational European observational cohort study [PDF]
, 2023 Background: The European Confederation of Medical Mycology (ECMM) collected data on epidemiology, risk factors, treatment, and outcomes of patients with culture-proven candidaemia across Europe to assess how adherence to guideline recommendations is ...
core +1 more source